Batten disease

PerkinElmer to Provide Testing for BioMarin Program in Mexico

PerkinElmer will provide biochemical and genetic testing to support BioMarin's testing program aimed at Batten disease and mucopolysaccharidosis disorders.

Breaking News

Batten disease

PerkinElmer to Provide Testing for BioMarin Program in Mexico

International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time

Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests

In Brief This Week: Myriad Genetics, Thermo Fisher Scientific, DeepUll, Roche, Immunovia, More

Cepheid Tuberculosis Assay Receives WHO Prequalification

VA Offering No-Cost PGx Testing Through End of 2025

GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients